Correlation Between Interdialytic Weight Gain and Cardiovascular Diseases in Children With End-Stage Kidney Disease Undergoing Hemodialysis
1 other identifier
observational
75
1 country
1
Brief Summary
This study aimed to discuss the correlation between interdialytic weight gain and cardiovascular diseases in children with end-stage kidney disease undergoing chronic hemodialysis. The cardiovascular parameters used include left ventricular hypertrophy, systolic and diastolic function, carotid intima-media thickness, myocardial circumferential strain, and strain rate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 8, 2022
CompletedFirst Submitted
Initial submission to the registry
September 17, 2022
CompletedFirst Posted
Study publicly available on registry
September 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2023
CompletedSeptember 30, 2022
September 1, 2022
8 months
September 17, 2022
September 29, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation between interdialytic weight gain and cardiovascular diseases in children with end-stage kidney disease undergoing hemodialysis
Correlation between interdialytic weight gain and cardiovascular diseases in children with end-stage kidney disease undergoing hemodialysis
Through study completion, an average of 1 year
Interventions
interdialytic weight gain during hemodialysis
Eligibility Criteria
End-stage kidney disease children aged 2-18 years old
You may qualify if:
- End-stage kidney disease (chronic kidney disease stage 5)
- Undergo hemodialysis at least twice a week
You may not qualify if:
- History of congenital heart disease
- Critically ill patients with unstable hemodynamic status
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cipto Mangunkusumo Hospital
Jakarta Pusat, Jakarta Special Capital Region, 10430, Indonesia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Henny A Puspitasari, dr. Sp.A(K)
Department of Child Health, Faculty of Medicine, University of Indonesia - Cipto Mangunkusumo Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant of Pediatric Nephrology
Study Record Dates
First Submitted
September 17, 2022
First Posted
September 22, 2022
Study Start
July 8, 2022
Primary Completion
March 1, 2023
Study Completion
July 1, 2023
Last Updated
September 30, 2022
Record last verified: 2022-09